Co-Authors
This is a "connection" page, showing publications co-authored by Anton PottegÄrd and Simone Israelsen.
Connection Strength
0.294
-
Comparable COVID-19 outcomes with current use of GLP-1 receptor agonists, DPP-4 inhibitors or SGLT-2 inhibitors among patients with diabetes who tested positive for SARS-CoV-2. Diabetes Obes Metab. 2021 06; 23(6):1397-1401.
Score: 0.232
-
Venous Thromboembolism and Major Bleeding in Patients With Coronavirus Disease 2019 (COVID-19): A Nationwide, Population-Based Cohort Study. Clin Infect Dis. 2021 12 16; 73(12):2283-2293.
Score: 0.062